Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

657
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
657
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

833
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
833
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

873
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
873
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

945
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
945

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Universal Free Contraception Coverage Policy, Out-of-Pocket Payments, and Costs.

JAMA health forum·2026
Same author

The Longer-Term Impact of Biosimilar Switching Policies in Patients With Inflammatory Bowel Disease in British Columbia, Canada: A Retrospective, Population-Based Study.

Pharmacoepidemiology and drug safety·2026
Same author

Impact of Hepatitis C screening and treatment among incarcerated populations in Alberta, Canada on population-level Hepatitis C elimination efforts.

The International journal on drug policy·2026
Same author

Meta-Analysis: Prevalence of Eating Disorders in Inflammatory Bowel Disease.

Alimentary pharmacology & therapeutics·2025
Same author

A method to identify prescription drug targets for health technology reassessment.

International journal of technology assessment in health care·2025
Same author

The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeur.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2025
Same journal

FUT2-Mediated Fucosylation of OLFM4 Promotes Colon Cancer Cell Differentiation.

Canadian journal of gastroenterology & hepatology·2026
Same journal

Development and Validation of the Steatotic Liver Disease Lab Data Index: A Refined Diagnostic Tool.

Canadian journal of gastroenterology & hepatology·2026
Same journal

Independent Prognosis Prediction of Hepatocellular Carcinoma Using MicroRNA-Based Single and Combined Biomarkers.

Canadian journal of gastroenterology & hepatology·2026
Same journal

Risk Group Stratification for True Early Recurrence After Ablation for Hepatomas.

Canadian journal of gastroenterology & hepatology·2026
Same journal

Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.

Canadian journal of gastroenterology & hepatology·2026
Same journal

Impact of Cirrhosis Etiology and Intensive Care Accessibility on Upper Gastrointestinal Bleeding: A Prospective Observational Study.

Canadian journal of gastroenterology & hepatology·2026
See all related articles

Related Experiment Video

Updated: Apr 10, 2026

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
08:20

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

Published on: July 12, 2018

14.2K

Ulcerative colitis-associated hospitalization costs: a population-based study.

Stephanie Coward, Steven J Heitman, Fiona Clement

    Canadian Journal of Gastroenterology & Hepatology
    |June 17, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Hospitalization costs for ulcerative colitis (UC) increased significantly following colectomy procedures and infliximab use. These factors were identified as key predictors of higher healthcare expenses for UC patients requiring hospital admission.

    More Related Videos

    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
    06:16

    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

    Published on: August 9, 2024

    1.1K
    E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
    06:28

    E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

    Published on: August 1, 2019

    9.4K

    Related Experiment Videos

    Last Updated: Apr 10, 2026

    Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
    08:20

    Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

    Published on: July 12, 2018

    14.2K
    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
    06:16

    Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

    Published on: August 9, 2024

    1.1K
    E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
    06:28

    E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

    Published on: August 1, 2019

    9.4K

    Area of Science:

    • Gastroenterology
    • Health Economics
    • Clinical Pharmacy

    Background:

    • Hospitalization costs for ulcerative colitis (UC) have not been previously evaluated following the introduction of infliximab.
    • Understanding cost predictors is crucial for resource allocation and patient management.

    Purpose of the Study:

    • To identify predictors of hospitalization costs in patients with ulcerative colitis (UC) admitted for a flare or colectomy.
    • To analyze cost trends and the impact of specific treatments on healthcare expenditure.

    Main Methods:

    • Population-based surveillance identified adult UC patients hospitalized between 2001-2009.
    • Patients were stratified by admission type: medical therapy, emergent colectomy, or elective colectomy.
    • Linear regression and joinpoint analysis assessed cost predictors and trends, adjusting for clinical factors and infliximab use.

    Main Results:

    • Median hospitalization costs varied significantly by admission type, with emergent colectomy being the highest.
    • Adjusted hospitalization costs demonstrated an annual increase of approximately 6.0%.
    • In-hospital infliximab use independently predicted a 69.5% increase in costs.

    Conclusions:

    • Hospitalization costs for ulcerative colitis are significantly influenced by colectomy procedures and the use of infliximab.
    • Colectomy and infliximab are independent predictors of increased healthcare costs in UC patients.
    • No inflection point in hospital costs was identified after infliximab's introduction, suggesting a continuous rise.